Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is MEMANTINE HYDROCHLORIDE USP, with a corresponding US DMF Number 20362.
Remarkably, this DMF maintains an Active status since its submission on March 23, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 23, 2013, and payment made on July 08, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II